SCHEMBL2647875

SCHEMBL2647875

CCC/C=C/c1c(C(C)C)nc(C(C)C)c(CO)c1-c1ccc(OC)cc1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2647531 1.00 GCGR (0.54) GCGR
SCHEMBL2649231 0.87 GCGR (0.57) GCGR
SCHEMBL2647858 0.87 GCGR (0.61) GCGR
SCHEMBL2648795 0.87 GCGR (0.57) GCGR
SCHEMBL2647855 0.87 GCGR (0.61) GCGR
SCHEMBL2648100 0.87 GCGR (0.65) GCGR
SCHEMBL2648103 0.87 GCGR (0.65) GCGR
SCHEMBL2664163 0.86 GCGR (0.56) GCGR
SCHEMBL2648226 0.86 GCGR (0.56) GCGR
SCHEMBL2647431 0.86 GCGR (0.72) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218431-B1 GLUCAGON RECEPTOR ANTAGONISTS FOR THERAPY OF DIABETES AND CONDITIONS ASSOCIATED WITH DIABETES BAYER CORPORATION 2001-04-17 US disclosed